<p>B6-Ly5.2/Cr mice were transplanted with BALB/c skin grafts and were treated with 10<sup>7</sup> BALB/c DST and/ or anti-CD154 mAb, where indicated. A. Representative flow plots of CD44<sup>high</sup> and CD62L<sup>low</sup> CD8<sup>+</sup> T cells isolated from spleens of mice on day 7 post-transplantation. B. Expansion kinetics of activated CD8<sup>+</sup> T cells after allo-transplantation. C. Accumulation of CD44<sup>high</sup> CD62L<sup>low</sup> CD8<sup>+</sup> T cells on day 10, 14, and 50 post-transplantation. Data are summary of two experiments with three mice per group. Values are mean ± SEM. *p<0.05, **p<0.01, ***p<0.001.</p
<p>(<b>A–F</b>) CD4<sup>+</sup>CD44<sup>+</sup>CD62L<sup>+</sup> (T<sub>CM</sub>) and CD4<sup>+</sup...
<p>C57BL/6 aged and young CD45.2<sup>+</sup>, Thy1.2<sup>+</sup> mice were adoptively transferred wi...
<p>Cells from spleens and dLNs from 20 weeks wide-type and <i>lpg2–</i>infected mice were stained wi...
<p>B6-Ly5.2/Cr mice were transplanted with BALB/c skin grafts and were treated with 10<sup>7</sup> B...
<p>B6-Ly5.2/Cr mice were transplanted with BALB/c skin grafts and were treated with 10<sup>7</sup> B...
<p>Thy1.2 C57BL/6 mice that healed their primary low dose (1×10<sup>3</sup>) or high dose (2×10<sup>...
<p>Impaired proliferation of alloantigen-specific CD4<sup>+</sup> T-cells leads to prolonged graft s...
<p>Spleen cells and T-cell-depleted BM cells from WT B6.SJL mice (CD45.1<sup>+</sup>) were injected ...
<p>Old alloreactive effector/memory CD4<sup>+</sup> T-cells proliferate less in response to antigen....
<p>Mice (3/group) which had been transplanted i.p. with 3 × 10<sup>6</sup> ID8 cells 10 days earlier...
<p>A. B6-Ly5.2/Cr mice were transplanted with BALB/c skin grafts and were treated with 10<sup>7</sup...
<p>C57BL/6 mice infected with low dose (1×10<sup>3</sup>) and high dose (2×10<sup>6</sup>) <i>L. maj...
<p>Male skin grafts were transplanted onto females recipients treated or not at days −1, 6 and 13 po...
<p>Splenocytes from C57BL/6 WT, C57BL/6 WT treated with CTLA4Ig or CD28<sup>−/−</sup> recipients of ...
<p>C57BL/6 mice were treated twice with 250 µg anti-CD4 Ab (GK1.5 Harlan) two and one day prior to i...
<p>(<b>A–F</b>) CD4<sup>+</sup>CD44<sup>+</sup>CD62L<sup>+</sup> (T<sub>CM</sub>) and CD4<sup>+</sup...
<p>C57BL/6 aged and young CD45.2<sup>+</sup>, Thy1.2<sup>+</sup> mice were adoptively transferred wi...
<p>Cells from spleens and dLNs from 20 weeks wide-type and <i>lpg2–</i>infected mice were stained wi...
<p>B6-Ly5.2/Cr mice were transplanted with BALB/c skin grafts and were treated with 10<sup>7</sup> B...
<p>B6-Ly5.2/Cr mice were transplanted with BALB/c skin grafts and were treated with 10<sup>7</sup> B...
<p>Thy1.2 C57BL/6 mice that healed their primary low dose (1×10<sup>3</sup>) or high dose (2×10<sup>...
<p>Impaired proliferation of alloantigen-specific CD4<sup>+</sup> T-cells leads to prolonged graft s...
<p>Spleen cells and T-cell-depleted BM cells from WT B6.SJL mice (CD45.1<sup>+</sup>) were injected ...
<p>Old alloreactive effector/memory CD4<sup>+</sup> T-cells proliferate less in response to antigen....
<p>Mice (3/group) which had been transplanted i.p. with 3 × 10<sup>6</sup> ID8 cells 10 days earlier...
<p>A. B6-Ly5.2/Cr mice were transplanted with BALB/c skin grafts and were treated with 10<sup>7</sup...
<p>C57BL/6 mice infected with low dose (1×10<sup>3</sup>) and high dose (2×10<sup>6</sup>) <i>L. maj...
<p>Male skin grafts were transplanted onto females recipients treated or not at days −1, 6 and 13 po...
<p>Splenocytes from C57BL/6 WT, C57BL/6 WT treated with CTLA4Ig or CD28<sup>−/−</sup> recipients of ...
<p>C57BL/6 mice were treated twice with 250 µg anti-CD4 Ab (GK1.5 Harlan) two and one day prior to i...
<p>(<b>A–F</b>) CD4<sup>+</sup>CD44<sup>+</sup>CD62L<sup>+</sup> (T<sub>CM</sub>) and CD4<sup>+</sup...
<p>C57BL/6 aged and young CD45.2<sup>+</sup>, Thy1.2<sup>+</sup> mice were adoptively transferred wi...
<p>Cells from spleens and dLNs from 20 weeks wide-type and <i>lpg2–</i>infected mice were stained wi...